ION-736

N/A

Report date: 2021/12/20 09:52:02
NME

Base Information

Drug NameION-736
Drug Alias NameFoxp3 targeted antisense oligonucleotideAZD-8701IONIS-AZ7-2.5RxION-736Gen 2.5 cEt-modified ASOs +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionForkhead box protein P3 expression inhibitors
TargetsForkhead box protein P3
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsSmall Cell Lung Carcinoma +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsSmall Cell Lung Carcinoma +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A